The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

TD Cowen analyst Bryan Bergin maintained a Hold rating on Paychex (PAYX – Research Report) today and set a price target of $146.00. The ...

Gautam Khanna, analyst at TD Cowen, shares his outlook for Boeing and says it will take "a number of years" before the ...

Pembina Pipeline (NYSE:PBA) +0.5% in Wednesday's trading as analysts at TD Cowen call the stock its top pick for Canadian ...

TD Cowen initiated coverage of ConocoPhillips (COP) with a Buy rating and $125 price target The company’s “unique” scale, inventory depth and ...

Blue Owl Capital Inc (OWL) stock saw a modest uptick, ending the day at $23.4 which represents a slight increase of $0.49 or 2.14% from the prior close of $22.91. The stock opened at $23.15 and ...

Broadcom Inc (AVGO) stock saw a modest uptick, ending the day at $229.41 which represents a slight increase of $1.41 or 0.62% from the prior close of $228. The stock opened at $235.22 and touched a ...

With a finite number of carriers in most regions, the LTL industry is much more disciplined on pricing than the highly ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

SAP stock upgraded to Buy by TD Cowen, citing rise in ERP priority and AI driving cloud migrations. Read more here.

El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...

TD Cowen initiated coverage of KalVista (KALV) with a Buy rating and $30 price target The firm cites sebetralstat’s opportunity as the first oral acute therapy for hereditary angioedema attacks ...